CASI Pharmaceuticals, Inc. research brief

CIK 1962738 Copy CIK

Generated Nov. 7, 2026, 10:59 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: BEIJING F4. Reported legal jurisdiction: CAYMAN ISLANDS. These do not establish investor residence or where funds were deployed.

• April 28, 2026 · D · 0001962738-26-000004 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 5000000 USD.

• Feb. 26, 2026 · D · 0001962738-26-000003 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 5000000 USD.

• Jan. 28, 2026 · D · 0001962738-26-000002 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 5000000 USD.

• Jan. 28, 2026 · D · 0001962738-26-000001 · Source evidence

  Reported offering amount: 5000000 USD. Reported amount sold: 5000000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “CASI Pharmaceuticals, Inc. research brief,” CIK 1962738, retrieved Nov. 7, 2026, 10:59 p.m.. Cite the specific accessions used. No amounts have been summed.